bf/NASDAQ:BIOR_icon.jpeg

COM:BIORATHERAPEUTICS

Biora Therapeutics, Inc.

  • Stock

USD

Last Close

1.63

22/11 21:00

Market Cap

23.40M

Beta: -

Volume Today

82.22K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
-129.11M
-
-148.04M
14.66%
-192.53M
30.05%
-178.52M
7.28%
-38.16M
78.63%
-124.11M
225.27%
depreciation and amortization
6.07M
-
6.35M
4.54%
5.06M
20.32%
1.44M
71.60%
907K
36.88%
555K
38.81%
deferred income tax
6.25M
-
58.57M
-
21.93M
62.56%
stock based compensation
2.26M
-
2.38M
4.95%
10.67M
349.18%
11.96M
12.13%
7.80M
34.76%
16.48M
111.11%
change in working capital
46.16M
-
32.65M
29.26%
-51.17M
256.70%
-25.86M
49.45%
-4.65M
82.02%
-1.17M
74.80%
accounts receivables
584K
-
3.43M
487.16%
9.51M
177.28%
-828K
-
inventory
-3.48M
-
-3.86M
10.99%
-1.43M
63.05%
828K
-
accounts payables
5.77M
-
4.38M
24.04%
2.86M
34.82%
-8.69M
404.03%
-5.07M
41.61%
-1.17M
76.89%
other working capital
43.28M
-
28.70M
33.69%
-62.11M
316.42%
-17.18M
72.34%
422K
102.46%
1.17M
177.73%
other non cash items
3.24M
-
535K
83.48%
3.66M
583.36%
1.57M
57.00%
-30.32M
2,028.82%
58.59M
293.22%
net cash provided by operating activities
-65.13M
-
-106.12M
62.95%
-165.74M
56.18%
-167.49M
1.05%
-64.42M
61.54%
-48.50M
24.71%
investments in property plant and equipment
-4.83M
-
-3.73M
22.91%
-4.94M
32.72%
-855K
82.71%
-792K
7.37%
-103K
86.99%
acquisitions net
50K
-
purchases of investments
-167.01M
-
-11.21M
93.29%
sales maturities of investments
227.67M
-
31.41M
86.20%
other investing activites
-387K
-
11K
-
net cash used for investing activites
55.83M
-
16.52M
70.40%
-4.94M
129.92%
-1.24M
74.88%
-792K
36.23%
-92K
88.38%
debt repayment
-1.75M
-
-1.27M
27.14%
-983K
22.90%
-1.64M
67.14%
-12K
99.27%
common stock issued
459K
-
551K
20.04%
116.44M
21,031.58%
46.78M
59.83%
9.01M
80.73%
18.14M
101.21%
common stock repurchased
-11.27M
-
79.04M
801.57%
98K
-
dividends paid
-4.50M
-
other financing activites
-250K
-
-179K
28.40%
114.27M
63,937.99%
119.92M
4.94%
-1.80M
101.50%
12.64M
801.66%
net cash used provided by financing activities
-12.81M
-
73.64M
674.97%
229.72M
211.97%
165.05M
28.15%
7.30M
95.58%
30.78M
321.77%
effect of forex changes on cash
9.29M
-
2.54M
-
net change in cash
-22.10M
-
-15.96M
27.78%
59.03M
469.82%
-3.68M
106.23%
-57.91M
1,474.10%
-15.28M
73.62%
cash at beginning of period
71.11M
-
49.01M
31.08%
33.04M
32.57%
92.08M
178.66%
88.40M
4.00%
30.49M
65.51%
cash at end of period
49.01M
-
33.04M
32.57%
92.08M
178.66%
88.40M
4.00%
30.49M
65.51%
15.21M
50.10%
operating cash flow
-65.13M
-
-106.12M
62.95%
-165.74M
56.18%
-167.49M
1.05%
-64.42M
61.54%
-48.50M
24.71%
capital expenditure
-4.83M
-
-3.73M
22.91%
-4.94M
32.72%
-855K
82.71%
-792K
7.37%
-103K
86.99%
free cash flow
-69.96M
-
-109.85M
57.02%
-170.69M
55.38%
-168.34M
1.38%
-65.21M
61.26%
-48.60M
25.47%

All numbers in USD (except ratios and percentages)